Treatment Registry
TR-0825 ActiveRecorded September 2026

Compounded tirzepatide

Sold by Idgie Health · Injection, vial · every compounded tirzepatide record

Recorded initial charges

First month

$229

first month, including required fees on record. The published monthly rate excludes one-time and annual fees; introductory and conditional rates may change. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.

Medication · 1 month, billed monthly · recorded initial monthly payment$229

Added from the figures recorded below.

Price

TermPer monthCharged today
1 month, billed monthlyAdvertised

“1 Month Billed monthly, flexible $229 /mo”

Per month$229Charged today$229
3 months, billed today

“3 Months 3-month supply, save $130 $185 /mo $557 billed today, then every 3 months”

Per month$185Charged today$557
6 months, billed today

“6 Months 6-month supply, save $345 $171 /mo $1029 billed today, then every 6 months”

Per month$171Charged today$1,029
Price sources
Visit Idgie Health

We earn nothing from this link. It opens Idgie Health's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

PharmacyVialsRX · TX
StatesAll 50 states
PrescriberAsynchronous review
CancellationPause or cancel anytime
MembershipNot disclosed
Consult feeNone. “Your plan covers the full provider evaluation, all medication and injection supplies, a personalized dose-titration schedule, unlimited provider messaging, and free shipping. No hidden fees”

Recorded from idgiehealth.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0825
Medication category
compounded tirzepatide
Readings
1

Related records

Other records from Idgie Health

All Idgie Health programs and terms

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 374 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Idgie Health — compounded tirzepatide (TR-0825). Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0825

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.